Reaping the benefits of genomic and proteomic research : intellectual property rights, innovation, and public health /
The patenting and licensing of human genetic material and proteins represents an extension of intellectual property (IP) rights to naturally occurring biological material and scientific information, much of it well upstream of drugs and other disease therapies. This report concludes that IP restrict...
| Corporate Authors: | , |
|---|---|
| Other Authors: | , |
| Format: | Book |
| Language: | English |
| Published: |
Washington, D.C. :
National Academies Press,
c2006
Washington, D.C. : ©2006 |
| Subjects: |
Table of Contents:
- Genomics, proteomics, and the changing research environment
- The U.S. patent system, biotechnology, and the courts
- Trends in the patenting and licensing of genomic and protein inventions and their impact on biomedical research
- Conclusions and recommendations
- note: 1 Introduction
- 2. Genomics, proteomics, and the changing research environment
- 3. U.S. patent system, biotechnology and the courts
- 4. Trends in the patenting and licensing of genomic and protein inventions and their impact on biomedical research
- 5. Conclusions and recommendations
- App. A Biographical information of committee and staff.